Author:
Singh Bal Ram,Kumar Raj,Cai Shuowei
Reference182 articles.
1. Adler, M., McDonald, D. A., Sellin, L. C., & Parker, G. W. (1996). Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin. Toxicon, 34(2), 237–249.
2. Adler, M., Keller, J. E., Sheridan, R. E., & Despande, S. S. (2001). Persistence of botulinum neurotoxin. A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Toxicon, 39, 233–243.
3. Ahmed, S. A., & Smith, L. A. (2000). Light chain of botulinum A neurotoxin expressed as an inclusion. Body from a synthetic gene is catalytically and functionally active. Journal of Protein Chemistry, 19, 475–487.
4. Ala-Huikku Nurmi, K. E., Pajulahti, H., & Raevuori, M. (1977). The occurrence of Clostridium botulinum type E in Finnish trout farms and the prevention of toxin formation in fresh-salted vacuum-packed trout fillets. Nordisk Veterinaermedicin, 29, 386–391.
5. Antonucci, F., Di Garbo, A., Novelli, E., Manno, I., Sartucci, F., Bozzi, Y., & Caleo, M. (2008). Botulinum neurotoxin E reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Experimental. Neurology, 210, 388–401.